Skip to main content

On Friday 13th December, staff from NECCR attended the public launch of the newly formed Newcastle University Centre for Cancer

Led by Professor Steve Clifford, it was a really inspiring event which demonstrated why Newcastle has such strength in Cancer Research and how that translates into developing new treatments for patients.

The vision for the new Centre is to keep Newcastle at the leading edge of cancer research, but also to be able to share that out in the wider world, for the benefit of all. The NECCR is extremely proud to be able to fund children’s cancer research at Newcastle University and will continue to do so through this new centre.

What we learnt is that Newcastle really is special.

It has an incredible hospital in the Royal Victoria Infirmary, which links clinical professionals with academics and scientists through the University’s Centre for Cancer and this means that patients here in the North East have the opportunity to participate in early phase trials having access to treatments that you couldn’t get in other geographical areas.

Professor Sir John Burn (Chair of Newcastle Hospital NHS Foundation Trust) said at the event that the charitable sector contributed greatly to being able to fund this work and that 61 ‘first in human’ trials were currently in process throughout all of the different areas of cancer within the Trust.

Newcastle currently has the 3rd biggest cancer centre in the UK (soon to be the 2nd). It was also named by Newsweek as one of the top 100 hospitals in the world and came 2nd in the UK in 2019.

The research into children’s cancer in North East England, which in part is funded by the NECCR helps contribute to this bigger picture. It means that the brightest minds want to study here, practice here and continue their research here. That ultimately means that young people affected by cancer in this region get the best possible treatment and care.

It’s something to really be proud of, and something that is vital that we keep investing in.

Want to help us continue to fund vital research?

Back to top